MeSH tree: C15.604.515.569.480
New data published in The Journal of Immunology has revealed the role of Plasmodium falciparum infection (malaria) in the development of Burkitt lymphoma (BL), the most common childhood cancer in equatorial Africa and New ...
Apr 25, 2025
0
30
Researchers at MIT have developed a noninvasive medical monitoring device powerful enough to detect single cells within blood vessels, yet small enough to wear like a wristwatch. One important aspect of this wearable device ...
Apr 24, 2025
0
52
Diffuse large B-cell lymphoma (DLBCL) is the most common and fast-growing type of non-Hodgkin lymphoma, a cancer that affects the lymphatic system. It makes up around 30–40% of adult non-Hodgkin lymphoma cases worldwide. ...
Apr 22, 2025
0
12
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates for patients with refractory ...
Apr 4, 2025
0
32
Researchers with City of Hope and Memorial Sloan Kettering (MSK) Cancer Center have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient's likely response to chimeric antigen receptor (CAR) ...
Apr 1, 2025
0
30
Being born with a heart defect may be associated with an increased cancer risk for babies and their moms, according to new research published in Circulation.
Mar 17, 2025
0
15
Researchers have discovered and analyzed a rare but serious side effect of an innovative form of blood cancer therapy. The scientists from the University of Leipzig Medical Center, the Fraunhofer Institute for Cell Therapy ...
Feb 21, 2025
0
32
Northwestern Medicine scientists have uncovered a key pathway controlling tumor growth in B-cell lymphomas, according to a study published in the Journal of Clinical Investigation.
Feb 3, 2025
0
19
An international team of doctors led by Joshua Brody, MD, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute at Mount Sinai, has made a major breakthrough in treating a common and challenging form ...
Jan 23, 2025
0
19
A fusion protein therapy may be an effective treatment option for cutaneous T-cell lymphomas, according to a multicenter clinical trial published in the Journal of Clinical Oncology.
Jan 20, 2025
0
14
